Frank Rimerman Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.92M | Buy |
31,907
+4,291
| +16% | +$796K | 0.4% | 41 |
|
|
2025
Q1 | $5.79M | Buy |
27,616
+475
| +2% | +$99.5K | 0.46% | 34 |
|
|
2024
Q4 | $4.82M | Buy |
27,141
+404
| +2% | +$71.8K | 0.35% | 39 |
|
|
2024
Q3 | $5.28M | Buy |
26,737
+682
| +3% | +$135K | 0.37% | 40 |
|
|
2024
Q2 | $4.47M | Buy |
26,055
+26,019
| +72,275% | +$4.46M | 0.32% | 43 |
|
|
2024
Q1 | $6.56K | Hold |
36
| – | – | ﹤0.01% | 196 |
|
|
2023
Q4 | $5.58K | Buy |
+36
| New | +$5.58K | ﹤0.01% | 194 |
|
|
2021
Q2 | – | Sell |
-1,945
| Closed | -$210K | – | 83 |
|
|
2021
Q1 | $210K | Buy |
+1,945
| New | +$210K | 0.09% | 81 |
|